Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMBRaCE-GM: Wearable Monitors in Cancer
NCT05099237Unknown
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Dec 2021
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Open-label trial (3 cohorts), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Feasibility of monitoring for each wearable monitor at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT05099237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05099237.